The effect of valve type and drive line dP/dt on hemolysis in the pneumatic ventricular assist device

Downsizing of a Pulsatile Total Artificial Heart-The Effect on Hemolysis

A downsized version of the ReinHeart total artificial heart (TAH) was developed. Hemocompatibility needs to be revised since the operating point of the downsized TAH has changed to a higher pump frequency to accomplish the same cardiac output. A mock circulation loop was designed, containing a left side for hemocompatibility testing and a right side to mimic realistic work conditions. A protocol for hemolysis testing was established using pooled porcine blood with an operation point of 5 L/min, a mean outlet pressure of 100 mm Hg and a mean inlet pressure of 12 mm Hg. Six trials were performed testing two downsized TAH (one with a compliance chamber [CC] connected, necessary for a pneumatic decoupling of both membranes and one open to atmosphere) and a BPX-80 as reference pump. The average modified index of hemolysis and normalized index of hemolysis (NIH in mg/100L) from six individual trials of the reference pump were 0.34 (0.07) and 3.21 (0.61) and of the TAH open to atmosphere 4.18 (1.19) and 38.85 (10.59), respectively. In between TAH with and without CC, there was no significant difference. A NIH ratio of TAH and reference pump was calculated to minimize variation of the different blood batches used in individual trials. Due to the downsizing, the ReinHeart's hemolysis level increased by around 22% compared with the original size version. Comparing the results to clinically approved left ventricular assist devices, the level of hemolysis can still be considered acceptable.

Circulatory loop design and components introduce artifacts impacting in vitro evaluation of ventricular assist device thrombogenicity: A call for caution

Mechanical circulatory support (MCS) devices continue to be hampered by thrombotic adverse events (AEs), a consequence of device-imparted supraphysiologic shear stresses, leading to shear-mediated platelet activation (SMPA). In advancing MCS devices from design to clinical use, in vitro circulatory loops containing the device under development and testing are utilized as a means of assessing device thrombogenicity. Physical characteristics of these test circulatory loops may also contribute to inadvertent platelet activation through imparted shear stress, adding inadvertent error in evaluating MCS device thrombogenicity. While investigators normally control for the effect of a loop, inadvertent addition of what are considered innocuous connectors may impact test results. Here, we tested the effect of common, additive components of in vitro circulatory test loops, that is, connectors and loop geometry, as to their additive contribution to shear stress via both in silico and in vitro models. A series of test circulatory loops containing a ventricular assist device (VAD) with differing constituent components, were established in silico including: loops with 0~5 Luer connectors, a loop with a T-connector creating 90° angulation, and a loop with 90° angulation. Computational fluid dynamics (CFD) simulations were performed using a k - ω shear stress transport turbulence model to platelet activation index (PAI) based on a power law model. VAD-operated loops replicating in silico designs were assembled in vitro and gel-filtered human platelets were recirculated within (1 hour) and SMPA was determined. CFD simulations demonstrated high shear being introduced at non-smooth regions such as edge-connector boundaries, tubing, and at Luer holes. Noticeable peaks' shifts of scalar shear stress (sss) distributions toward high shear-region existed with increasing loop complexity. Platelet activation also increased with increasing shear exposure time, being statistically higher when platelets were exposed to connector-employed loop designs. The extent of platelet activation in vitro could be successfully predicted by CFD simulations. Loops employing additional components (non-physiological flow pattern connectors) resulted in higher PAI. Loops with more components (5-connector loop and 90° T-connector) showed 63% and 128% higher platelet activation levels, respectively, versus those with fewer (0-connector (P = .023) and a 90° heat-bend loop (P = .0041). Our results underscore the importance of careful consideration of all component elements, and suggest the need for standardization in designing in vitro circulatory loops for MCS device evaluation to avoid inadvertent additive SMPA during device evaluation, confounding overall results. Specifically, we caution on the use and inadvertent introduction of additional connectors, ports, and other shear-generating elements which introduce artifact, clouding primary device evaluation via introduction of additive SMPA.

Development of a closed air loop electropneumatic actuator for driving a pneumatic blood pump

In this study, we developed a small pneumatic actuator that can be used as an extracorporeal biventricular assist device. It incorporated a bellows-transforming mechanism to generate blood-pumping pressure. The cylindrical unit is 88 +/- 0.1 mm high, has a diameter of 150 +/- 0.1 mm, and weighs 2.4 +/- 0.01 kg. In vitro, maximal outflow at the highest pumping rate (PR) exceeded 8 L/min when two 55 mL blood sacs were used under an afterload pressure of 100 mm Hg. At a pumping rate of 100 beats per minute (bpm), maximal hydraulic efficiency was 9.34% when the unit supported a single ventricle and 13.8% when it supported both ventricles. Moreover, pneumatic efficiencies of the actuator were 17.3% and 33.1% for LVAD and BVAD applications, respectively. The energy equivalent pressure was 62.78 approximately 208.10 mm Hg at a PR of 60 approximately 100 bpm, and the maximal value of dP/dt during systole was 1269 mm Hg/s at a PR of 60 bpm and 979 mm Hg/s at a PR of 100 bpm. When the unit was applied to 15 calves, it stably pumped 3 approximately 4 L/min of blood at 60 bpm, and no mechanical malfunction was experienced over 125 days of operation. We conclude that the presently developed pneumatic actuator can be utilized as an extracorporeal biventricular assist device.

Effect of the diastolic and systolic duration on valve cavitation in a pediatric pulsatile ventricular assist device

Minimization of cavitation is of high importance in the design of pulsatile ventricular assist devices because cavitation can cause blood and valve surface damage. Cavitation is associated with valve closure and has been previously correlated to high dP/dt, high valve closing velocity, and decreased pump filling. In this study, the effects of diastolic and systolic duration on the inlet and outlet valve cavitation were investigated. A low volume (280 ml) mock circulatory loop filled with room-temperature saline was used. A high-fidelity hydrophone was mounted into the inlet valve connector approximately 0.5 cm upstream from the inlet valve to quantify inlet valve cavitation. The inlet valve connector and hydrophone were placed symmetrically on the outlet side when measuring outlet valve cavitation. The RMS intensity of a 6-millisecond window pressure trace, bandpass filtered from 50 to 500 kHz, was used to quantify cavitation intensity. Approximately 80 beats were recorded at every test condition. High-speed video and an accelerometer were used to determine the position of the valves during closure. The cavitation intensity of the inlet valve was minimal when the onset of systole occurred at the moment when the pump just completed filling (RMS was approximately zero). The cavitation intensity increased when the onset of systole occurred before the pump was completely filled (valve partially opened), reaching a plateau of approximately 16 mm Hg when the valve was fully open. The cavitation intensity increased again when diastolic duration exceeded pump filling time by more than 30 milliseconds. The outlet valve cavitation intensity was very low (<4 mm Hg) regardless of the systolic duration, which can be attributed to the position of the hydrophone being on the opposite side of cavitation events. Although very small, the outlet cavitation intensities with respect to systolic duration show a trend similar to the inlet valve cavitation with respect to diastolic duration. Both inlet and outlet valve cavitation increased with increased peak regurgitant flow. An understanding of the relationship of the inlet and outlet valve cavitation to the diastolic and systolic duration can be used to determine the optimal operating conditions of the pulsatile pediatric pump.

The analysis of driving mode influence on energy dissipation in pneumatic artificial heart chambers

The energy dissipated in blood or on a total artificial heart (TAH) chamber's elements directly or indirectly decreases the biological or technical safety of the TAH's work. The energetic analysis of the Polish total artificial heart (POLTAH) external work with the objective of estimating the valve and membrane roles in energy dissipation has been performed. The simulation of left and right artificial heart chamber work under physiological conditions using a self-constructed physical model of the circulatory system has been performed for the full systole percent and frequency range and for different valves. The total energy dissipated on valves equals 15-30% of the chambers' work value. Energy losses on valves are influenced by the driving mode. The usage of inappropriate systolic and diastolic times increases the value of the energy dissipated on the membrane and on valves in the overall energy balance. The absolute value of the energy dissipated on the valves increases with the increase of the cycle time and depends on the valve type. The energy dissipated on the outlet valve decreases with the frequency (if the remaining driving parameters are kept constant) and for 150 bpm is nearly 3 times lower than that for 30 bpm. The energy dissipated on the membrane equals 10-50% of the TAH's work during systole, depending on the driving parameters. The filling process is assisted by the pressure from the atrium, and a great amount of energy during the diastolic period is consumed by the start of the membrane movement. We have also estimated the influence of the driving parameters on the valves' functions, measuring the acoustic wave intensity. The conclusions drawn are of a general character; they are applicable to all membrane, pneumatically powered blood pumps.

Effects of tilting disk heart valve gap width on regurgitant flow through an artificial heart mitral valve

While many investigators have measured the turbulent stresses associated with forward flow through tilting disk heart valves, only recently has attention been given to the regurgitant jets formed as fluid is squeezed through the gap between the occluder and housing of a closed valve. The objective of this investigation was to determine the effect of gap width on the turbulent stresses of the regurgitant jets through a Björk-Shiley monostrut tilting disk heart valve seated in the mitral position of a Penn State artificial heart. A 2 component laser-Doppler velocimetry system with a temporal resolution of 1 ms was used to measure the instantaneous velocities in the regurgitant jets in the major and minor orifices around the mitral valve. The gap width was controlled through temperature variation by taking advantage of the large difference between the thermal expansion coefficients of the Delrin occluder and the Stellite housing of Björk-Shiley monostrut valves. The turbulent shear stress and mean (ensemble averaged) velocity were incorporated into a model of red blood cell damage to assess the potential for hemolytic damage at each gap width investigated. The results revealed that the minor orifice tends to form stronger jets during regurgitant flow than the major orifice, indicating that the gap width is not uniform around the circumference of the valve. Based on the results of a red blood cell damage model, the hemolytic potential of the mitral valve decreases as the gap width increases. This investigation also established that the hemolytic potential of the regurgitant phase of valve operation is comparable to, if not greater than, the hemolytic potential of forward flow, consistent with experimental data on hemolysis.

A new mock circulatory loop and its application to the study of chemical additive and aortic pressure effects on hemolysis in the Penn State electric ventricular assist device

A new mock circulatory loop was developed for hemolysis studies associated with the Penn State electric ventricular assist device (EVAD). This flow loop has several advantages over previously designed loops. It is small enough to accommodate experiments in which only single units of blood are available, it is made out of biocompatible materials, it incorporates good geometry, and it provides normal physiological pressures and flows to both the aortic outlet and the venous inlet of the pumping device. Experiments with reduced aortic pressure but normal cardiac output showed that hemolysis in a loop with normal aortic blood pressure was significantly higher than that in a loop with lowered aortic pressure, thereby illustrating the importance of maintaining loop pressures as close as possible to those found in vivo. This data also imply that blood traveling through the left ventricle in an artificial heart may be subject to higher hemolysis rates than that traversing the right ventricle. Another set of experiments to determine the effects of 4 hemolysis or drag-reducing agents (Pluronic F-68, Dextran-40, Polyox WSR-301, and Praestol 2273TR) on blood trauma due to the EVAD and associated valves was performed. Results indicated that none of the additives significantly reduced hemolysis under the conditions found in the mock loop. Finally, a compilation of data gathered in these experiments showed that the index of hemolysis (IH) is dependent on hematocrit (HCT), which suggests that another parameter, IH/HCT, may be more suited to the quantification of hemolysis.